A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 18,614 shares of CORT stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,614
Previous 24,955 25.41%
Holding current value
$1.07 Million
Previous $810,000 6.3%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$29.51 - $46.26 $187,122 - $293,334
-6,341 Reduced 25.41%
18,614 $861,000
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $304,654 - $472,962
-13,717 Reduced 35.47%
24,955 $810,000
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $443,289 - $576,907
21,009 Added 118.94%
38,672 $974,000
Q4 2023

Feb 14, 2024

SELL
$24.82 - $32.88 $1,811 - $2,400
-73 Reduced 0.41%
17,663 $573,000
Q3 2023

Nov 14, 2023

SELL
$21.97 - $33.8 $89,330 - $137,430
-4,066 Reduced 18.65%
17,736 $483,000
Q2 2023

Aug 14, 2023

SELL
$21.44 - $25.15 $158,763 - $186,235
-7,405 Reduced 25.35%
21,802 $485,000
Q1 2023

May 15, 2023

SELL
$19.2 - $24.47 $277,593 - $353,787
-14,458 Reduced 33.11%
29,207 $632,000
Q4 2022

Feb 14, 2023

BUY
$19.95 - $29.96 $109,924 - $165,079
5,510 Added 14.44%
43,665 $886,000
Q3 2022

Nov 14, 2022

SELL
$24.7 - $29.12 $226,400 - $266,913
-9,166 Reduced 19.37%
38,155 $978,000
Q2 2022

Aug 15, 2022

SELL
$17.33 - $25.3 $36,722 - $53,610
-2,119 Reduced 4.29%
47,321 $1.13 Million
Q1 2022

May 16, 2022

BUY
$16.53 - $25.21 $9,818 - $14,974
594 Added 1.22%
49,440 $1.11 Million
Q4 2021

Feb 14, 2022

BUY
$17.1 - $23.34 $517,770 - $706,711
30,279 Added 163.08%
48,846 $967,000
Q3 2021

Nov 15, 2021

BUY
$19.68 - $22.53 $62,739 - $71,825
3,188 Added 20.73%
18,567 $365,000
Q2 2021

Aug 16, 2021

SELL
$19.97 - $24.43 $27,418 - $33,542
-1,373 Reduced 8.2%
15,379 $338,000
Q1 2021

May 17, 2021

SELL
$23.49 - $30.56 $230,460 - $299,824
-9,811 Reduced 36.93%
16,752 $399,000
Q4 2020

Feb 16, 2021

SELL
$16.78 - $27.3 $282,273 - $459,240
-16,822 Reduced 38.77%
26,563 $695,000
Q3 2020

Nov 16, 2020

BUY
$12.46 - $19.98 $179,100 - $287,192
14,374 Added 49.55%
43,385 $755,000
Q2 2020

Aug 13, 2020

SELL
$11.0 - $18.26 $476,652 - $791,242
-43,332 Reduced 59.9%
29,011 $488,000
Q1 2020

May 15, 2020

SELL
$10.11 - $14.04 $58,547 - $81,305
-5,791 Reduced 7.41%
72,343 $860,000
Q4 2019

Feb 14, 2020

BUY
$12.06 - $16.96 $357,868 - $503,271
29,674 Added 61.23%
78,134 $945,000
Q3 2019

Nov 14, 2019

SELL
$10.41 - $14.66 $288,638 - $406,477
-27,727 Reduced 36.39%
48,460 $685,000
Q2 2019

Aug 14, 2019

SELL
$9.78 - $12.76 $387,698 - $505,831
-39,642 Reduced 34.22%
76,187 $849,000
Q1 2019

May 15, 2019

SELL
$10.03 - $15.71 $69,848 - $109,404
-6,964 Reduced 5.67%
115,829 $1.36 Million
Q4 2018

Feb 14, 2019

BUY
$11.29 - $17.19 $751,157 - $1.14 Million
66,533 Added 118.26%
122,793 $1.64 Million
Q3 2018

Nov 14, 2018

SELL
$12.27 - $15.65 $168,847 - $215,359
-13,761 Reduced 19.65%
56,260 $789,000
Q2 2018

Aug 14, 2018

BUY
$15.3 - $19.69 $754,427 - $970,894
49,309 Added 238.07%
70,021 $1.1 Million
Q1 2018

May 15, 2018

BUY
$14.59 - $25.5 $41,990 - $73,389
2,878 Added 16.14%
20,712 $341,000
Q4 2017

Feb 14, 2018

SELL
$15.77 - $20.72 $766,674 - $1.01 Million
-48,616 Reduced 73.16%
17,834 $322,000
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $817,335 - $1.28 Million
66,450
66,450 $1.28 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.18B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.